KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Net Income towards Common Stockholders (2016 - 2025)

Evolent Health has reported Net Income towards Common Stockholders over the past 12 years, most recently at -$429.1 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$429.1 million for Q4 2025, down 1301.7% from a year ago — trailing twelve months through Dec 2025 was -$579.4 million (down 519.99% YoY), and the annual figure for FY2025 was -$579.4 million, down 519.99%.
  • Net Income towards Common Stockholders for Q4 2025 was -$429.1 million at Evolent Health, down from -$26.9 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for EVH hit a ceiling of $2.1 million in Q3 2022 and a floor of -$429.1 million in Q4 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was -$25.7 million (2023), compared with a mean of -$43.6 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 116.28% in 2022 and later plummeted 1663.64% in 2023.
  • Evolent Health's Net Income towards Common Stockholders stood at -$5.6 million in 2021, then tumbled by 100.97% to -$11.3 million in 2022, then crashed by 264.75% to -$41.4 million in 2023, then grew by 26.04% to -$30.6 million in 2024, then plummeted by 1301.7% to -$429.1 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$429.1 million (Q4 2025), -$26.9 million (Q3 2025), and -$51.1 million (Q2 2025) per Business Quant data.